RTX Company (NYSE:RTX) shares rose Tuesday after the corporate posted stronger-than-expected third-quarter 2025 outcomes and raised its full-year outlook.
Gross sales climbed 12% 12 months over 12 months to $22.478 billion, beating the $21.314 billion estimate. Adjusted EPS of $1.70 topped the $1.41 estimate, whereas GAAP EPS was $1.41, together with $0.29 of acquisition accounting changes, $0.01 of restructuring, and a $0.01 profit from different nonrecurring gadgets.
Working money circulate reached $4.639 billion, and free money circulate totaled $4.025 billion. RTX reported a backlog of $251 billion, with $148 billion in industrial and $103 billion in protection orders.
Additionally Learn: Raytheon Scores $5 Billion Coyote Missile Contract as Trump Pushes $1 Trillion Protection Price range
The corporate returned $900 million to shareholders, paid down $2.9 billion of debt, and accomplished the sale of Collins’ actuation and flight management enterprise.
Collins Aerospace gross sales rose 8% to $7.621 billion, pushed by larger industrial OE, aftermarket, and protection demand. Adjusted working revenue elevated 9% to $1.194 billion, helped by quantity beneficial properties that offset unfavorable combine and better tariffs.
Pratt & Whitney gross sales grew 16% to $8.423 billion, and adjusted revenue rose 26% to $751 million, supported by larger aftermarket and navy quantity, together with the F135 program.
Raytheon gross sales superior 10% to $7.045 billion, with adjusted revenue up 30% to $859 million on power in air and naval protection programs.
“Sturdy execution within the third quarter enabled us to ship double-digit natural gross sales progress throughout all three segments and our sixth consecutive quarter of year-over-year adjusted section margin growth,” mentioned Chairman and CEO Chris Calio.
“We additionally acquired $37 billion of recent awards within the quarter, reflecting sturdy world demand for our merchandise and supporting long-term progress for RTX,” he added.
Outlook
RTX raised its 2025 adjusted EPS outlook to $6.10–$6.20 from $5.80–$5.95, versus a $5.95 estimate, and lifted its adjusted gross sales forecast to $86.5–$87.0 billion from $84.75–$85.5 billion, above the $85.579 billion estimate. The corporate reaffirmed free money circulate steering of $7.0–$7.5 billion.
Value Motion: RTX inventory was buying and selling larger by 6.62% to $171.35 premarket eventually test Tuesday.
Learn Subsequent:
Photograph by T. Schneider through Shutterstock


Приємно бачити, як українська культура онлайн розквітає.
**hepatoburn**
hepatoburn is a potent, plant-based formula created to promote optimal liver performance and naturally stimulate fat-burning mechanisms.